peter hübner • micro music laboratories
M E D I C A L   R E S O N A N C E   T H E R A P Y   M U S I C®
R E D U C T I O N   O F   P S Y C H O – P H Y S I O L O G I C A L   M A N I F E S T A T I O N S   O F   S T R E S S

SCIENTIFIC RESEARCH

Research Fields Summary

Health of the Nervous System

Relaxation

Memory

Concentration

Headaches

Migraine

Multiple Sclerosis

Epilepsy

Dizziness

Arterial Nerves of the Arteries

Mental & Sensory Abilities

Cardiovascular Health

Health of the Hormone System

Health of the Immune System

Health of the Regenerative System

Healthy Sleep

Healthy Blood

Faster Recovery

Less Medication

Vital Energy

Relaxation

Release of STRESS

Harmony

Women’s Health

Pregnancy

Birth

Gynecological Surgery

Other Gynecological Problems

Children’s Health

Health of the Elderly

Health of Ear, Nose & Throat

Reduction of Pain

Headaches

Migraine

Birth

Health of the Skin

Neurodermatitis

Psoriasis

Health of Mind & Senses

Surgery

Psychological Health

Release of STRESS

Relaxation

Reduction of Anxiety

Courage to Face Life

Reducing Negative Values

Strengthening Positive Values

Harmony

Creativity

Exposure to Radioactivity

Mother & Child

 

 






Scientific Studies and Clinical Observations
PREGNANCY & BIRTH
  • Faster normalization of excessively high blood pressure in pregnant women with mild OPH syndrome than in the medication group
  • Significant reduction in the number of premature births – from 14% down to 6,2% – since the introduction of treatment with Medical Resonance Therapy Music® for pregnant women facing the risk of miscarriage
  • Faster breakdown of the protein content in the urine of pregnant women with OPH syndrome
  • Significantly better development of the kariopicnotic index in pregnant women facing the risk of miscarriage than in the control group and, as a result, a significantly better pregnancy
  • Dispersion of the clinical risk characteristics in pregnant women with a threat of miscarriage:
    after 2-3 days there were no longer any clinical risk characteristics in 60% of the women, in 100% after 5-7 days. In the control group: the clinical risk characteristics had disappeared in 70% after 7-10 days, in 30% there was no complete dispersion of the risk characteristics
  • Improvement in the foetal heart activity in pregnant women with OPH syndrome: 20 – 30% faster than in the control group
  • Significant improvement in the hormone status in pregnant women with somatic disorders leading to a significant increase in the well-being of mother and child, compared to only minor improvement in the control group
  • Taking of foetal heart activity out of the danger zone to a very satisfactory condition
  • Calming of the child inside the mother’s body during labor
  • Improvement of uterine activity: increased strength and a more harmonic rhythm of uterine contractions in women with an initial inactivity of the uterus during labor.
  • Reduction of anxiety during labor.
  • Reduction of pain during labor.
  • Reduction of hormonal manifestations of stress during labor.
  • Improvement of the general mental state in women with a mild OPH-syndrome.
  • Improvement of restless and depressive states in pregnant women with a threatening loss of pregnancy: in 69,2% of the women a total normalization of the psychic state occurred, no woman showed an aggravation of these symptoms. The results of the control group: in 40% a complete normalization, in 40% a further aggravation of the state.
  • Improvement of the immune status of pregnant women diagnosed for a threatening miscarriage: after the treatment the percentage of healthy women was 55% versus 46% in the control group.
  • Faster recovery of pregnant women with an OPH-syndrom: by 14% faster than in the control group.
  • Reducing the frequency of headache attacks in pregnant women from 73% to 20%. In the control group an increase from 60% to 70%.
  • Improvement of sleep in 77% of the pregnant women with a mild form of the OPH syndrome.
  • Improvement of sleep in 77% of the pregnant women with a mild form of the OPH syndrome. Reducing the frequency of sleep disorders from 86% to 7%. In the control group an increase from 50% to 80%.
  • Reduction of psycho-emotional stress by 47% versus no reduction in the control group.
  • Almost complete elimination of the risk factor stress in pregnant women: reducing the stress hormone cortisol by 36% while at the same time doubling the hormone progesterone.
 


  For this indication please use the program:

PREGNANCY & BIRTH
 
 
 

   If you want to look at the studies in detail, please visit:

With kind permission of AAR EDITION INTERNATIONAL
© 1998- SCIENTIFIC MUSIC MEDICINE | Contact

Subject to change in the interests of scientific advancement.